Sophia Hohenstatt
Overview
Explore the profile of Sophia Hohenstatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
26
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goertz L, Weyland C, Nikoubashman O, Burkle F, de Beukelaer F, Siebert E, et al.
Interv Neuroradiol
. 2025 Feb;
:15910199251318066.
PMID: 39995047
Objective: Phenox flow diverters (p64 and its smaller vessel variant p48) represent an established treatment option for intracranial aneurysms. This study evaluates the safety and efficacy of the new generation...
2.
Hohenstatt S, Costalat V, Dargazanli C, Killer-Oberpfalzer M, Schreiber B, Rautio R, et al.
J Neurointerv Surg
. 2025 Jan;
PMID: 39880621
Background: Intrasaccular devices have broadened treatment options for wide necked aneurysms. This study presents the preliminary experience with the Artisse 2.0 device. Methods: Innovative NeurovaScular Product SurveIllance REgistry (INSPIRE) is...
3.
Scarcia L, Clarencon F, Dmytriw A, Shotar E, Premat K, Jabbour P, et al.
J Neurointerv Surg
. 2024 Dec;
PMID: 39694804
Background: Data about the safety and the efficacy of flow diversion for distal anterior cerebral artery (DACA) aneurysms are limited. We present the largest multicenter analysis evaluating the outcomes of...
4.
Hohenstatt S, Vollherbst D, Miralbes S, Naravetla B, Spiotta A, Loehr C, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
PMID: 39627006
Background And Purpose: Mechanical thrombectomy (MT) is effective for acute ischemic stroke, yet its indication in mild stroke remains unclear. This study evaluates MT's effectiveness and safety in low NIHSS...
5.
Goertz L, Hohenstatt S, Vollherbst D, Styczen H, Siebert E, Bohner G, et al.
Neurosurgery
. 2024 Oct;
PMID: 39471102
Background And Objectives: Flow Redirection Endoluminal Device (FRED) X is a new generation flow diverter with an antithrombotic surface coating. This study compares the procedural safety and short-term efficacy of...
6.
Goertz L, Hohenstatt S, Vollherbst D, Weyland C, Nikoubashman O, Gronemann C, et al.
Interv Neuroradiol
. 2024 Oct;
30(6):819-826.
PMID: 39360399
Objective: This multicenter study evaluates the safety and efficacy of coated flow diverters (cFDs) for the treatment of cerebral aneurysms under single antiplatelet therapy (SAPT). Methods: This is a retrospective,...
7.
Goertz L, Hohenstatt S, Vollherbst D, Pflaeging M, Gronemann C, Siebert E, et al.
AJNR Am J Neuroradiol
. 2024 Aug;
45(10):1488-1494.
PMID: 39122468
Background And Purpose: The Pipeline Embolization Device is a safe and effective treatment option for intracranial aneurysms. The newer Pipeline generations have received structural refinements and a surface modification to...
8.
Goertz L, Hohenstatt S, Zopfs D, Kottlors J, Pennig L, Schlamann M, et al.
Interv Neuroradiol
. 2024 Jul;
:15910199241264340.
PMID: 39051598
Objective: The Pipeline Vantage Embolization Device (PVED) is a novel coated flow diverter with reduced wire diameters to improve neoendothelialization and stent porosity. This systematic review evaluates the safety and...
9.
Goertz L, Hohenstatt S, Vollherbst D, Weyland C, Nikoubashman O, Styczen H, et al.
J Neurointerv Surg
. 2024 Apr;
17(3):304-310.
PMID: 38569886
Background: This multicenter study evaluated the safety and efficacy of coated flow diverters (cFDs) for the treatment of ruptured intracranial aneurysms. Methods: Consecutive patients treated with different cFDs for ruptured...
10.
Hohenstatt S, Saatci I, Jesser J, Cekirge H, Kocer N, Islak C, et al.
AJNR Am J Neuroradiol
. 2024 Mar;
45(5):592-598.
PMID: 38453414
Background And Purpose: The optimal antiplatelet regimen after flow diverter treatment of cerebral aneurysms is still a matter of debate. A single antiplatelet therapy might be advantageous in determined clinical...